Cargando…
Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer’s disease
OBJECTIVE: Selective serotonin reuptake inhibitors (SSRIs) have increased cognitive performance in some clinical studies of Alzheimer’s disease (AD), but it is has been difficult to dissociate whether this is due to direct effects on cognition (neurochemical or disease-modifying) or a secondary effe...
Autores principales: | Chow, Tiffany W, Pollock, Bruce G, Milgram, Norton W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656299/ https://www.ncbi.nlm.nih.gov/pubmed/19300592 |
Ejemplares similares
-
SSRIs: Applications in inflammatory lung disease and implications for COVID‐19
por: Meikle, Claire Kyung Sun, et al.
Publicado: (2021) -
Pharmacogenetics of SSRIs and Sexual Dysfunction
por: Osis, Liana, et al.
Publicado: (2010) -
The potential action of SSRIs in the treatment of skin diseases including atopic dermatitis and slow-healing wounds
por: Kiecka, Aneta, et al.
Publicado: (2022) -
Antidepressants: From MAOIs to SSRIs and more
por: Ramachandraih, Chaitra T., et al.
Publicado: (2011) -
Continuing medical education: SSRIs and pregnancy
por: Andrade, Chittaranjan
Publicado: (2010)